Nexa3D Brings Additive Production Solutions to IMTS 2022
Nexa3D, the leading maker of ultrafast professional and industrial polymer 3D printers, today announced its plans to exhibit at IMTS, taking place September 12-17 in Chicago, Illinois. For its first showing at IMTS, Nexa3D is bringing its full – and rapidly expanding - additive manufacturing portfolio to Chicago.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220906005132/en/
The full suite of Nexa3D additive manufacturing solutions will be showcased at IMTS 2022, Additive Manufacturing Pavilion, Booth #432504 (Photo: Business Wire)
Among the real-world use cases highlighted at the booth will be the work with Applied Rapid Technologies (ART), where Nexa3D will demonstrate the benefits of owning the industrial 3D printing fleet for an on-demand manufacturing operation that replaces traditional urethane casting. Ultrafast, high performance resin 3D printing enables companies like ART to serve its customers’ needs in a more cost-effective manner and at a fraction of the time typically associated with traditional manufacturing methods. “Being a service provider with the Nexa3D machines - having 8 of them online now - just gives us more flexibility to take on projects and turn them around quickly. For years, we called this rapid prototyping, but it has really morphed into additive manufacturing,” said Bruce LeMaster, Vice President of Manufacturing at Obsidian Solutions Group.
“Nexa3D’s rapidly expanding product portfolio of ultrafast industrial solutions for the entire product life cycle democratizes access to industrial strength additive manufacturing tools, materials, and workflows for the benefit of small and large users. With no end in sight to persisting supply chain shortages, small and large product companies are more ready than ever before to explore digital manufacturing solutions and we are here to assist,” said Avi Reichental, CEO, and co-founder of Nexa3D.
Nexa3D’s end-to-end validated workflows, comprising its NexaX software platform, expanding functional polymer materials, and automated post processing deliver orders of magnitude better throughput and total cost of ownership advantages to businesses that are seeking to nearshore or localize parts of their supply chain operations. The company plans to showcase its latest industrial shop printers including its flagship NXE 400 and NXE 200 ultrafast 3D printers alongside its xCure, and xClean post-processing tools. The company also plans to introduce several new functional resins at the show.
As part of its rapidly expanding portfolio of manufacturing solutions, Nexa3D also plans to demonstrate the full power of its ultrafast XiP 3D printer in a production cell configuration, showcasing industry leading throughput, cost effectiveness, and functional material selection, powered by its open source platform enabling hyperlocal, flexible manufacturing.
The company plans to commercially launch previously announced QLS 820 high-productivity industrial sintering solution along with a powder processing system at IMTS. Designed for higher operating temperatures and broader powder processing windows, the QLS 820 offers the highest part throughput in its class, delivering unprecedented production throughput and flexibility. The system is a compelling alternative to traditional injection molding, designed with integration-ready Industry 4.0, lights-out manufacturing capabilities.
Nexa3D plans to take center stage on Wednesday, Sept. 14 at 1:00PM alongside its customer, PepsiCo, to talk about the latest manufacturing innovations in packaging design and development made possible by its ultrafast NXE 400 3D printers. More information and registration details available here.
As part of IMTS, the company plans to make several significant product commercialization announcements throughout the week from the show floor.
To learn more about the additive manufacturing solutions Nexa3D plans to exhibit at IMTS view the media kit.
About Nexa3D
Nexa3D is passionate about digitizing supply chains sustainably. The company makes ultrafast polymer 3D printers that deliver up to 20x productivity gains to professionals and businesses of all sizes. Partnerships with world-class material suppliers and its open materials platform unlock the full potential of additively manufactured polymers for volume production. Automated software tools optimize the entire production cycle using process interplay algorithms that ensure part performance and production consistency, while reducing waste, energy, and minimizing carbon footprints.
For more information on Nexa3D and its products, visit the Nexa3D website, or connect socially on LinkedIn, Twitter, Facebook, and Instagram.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220906005132/en/
Contact information
Nexa3D
Nina Swienton
Chief Marketing Officer
nina.swienton@nexa3d.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SK Capital Announces Definitive Agreement to Invest in Swixx BioPharma AG to Drive the Next Phase of Growth and Global Expansion15.12.2025 12:30:00 CET | Press Release
SK Capital Partners, LP (“SK Capital”), a New York-based private investment firm focused on the life sciences, specialty materials, and ingredients sectors, today announced that its affiliate has reached an agreement to invest in Swixx BioPharma AG (“Swixx” or the “Company”) to accelerate the Company’s next phase of growth and global expansion. The investment values the Company in excess of EUR €1.5 billion. Swixx is the global leader in rest-of-world pharmaceutical commercialization services dedicated to delivering innovative, life-saving medications to underserved and hard-to-reach markets. Stuart Swanson and Petr Němec, Swixx’s Co-Founders, and Jean-Michel Lespinasse and Petr Pipal, Swixx’s CEO and CFO, respectively, will all retain significant ownership stakes in Swixx as part of the transaction. Existing institutional investors HBM Healthcare Investments, a Swiss-listed investment company for the global healthcare market, and Mérieux Equity Partners, a leading healthcare-specializ
Safe Software Recognized as a Niche Player in 2025 Gartner® Magic Quadrant™ for Data Integration Tools15.12.2025 12:00:00 CET | Press Release
Safe Software, a global leader in data integration and transformation, has once again been recognized in the 2025 Gartner® Magic Quadrant™ for Data Integration Tools, marking the sixth consecutive year the company has been included in this prestigious report. Safe Software’s FME Platform has evolved well beyond its geospatial roots to become the only All-Data, Any-AI Integration Platform, empowering organizations worldwide to connect all data, applications, and AI technologies anywhere, at any scale, and with complete flexibility. With a community of more than 200,000 enthusiastic users and 25,000+ organizations in over 125 countries, FME continues to redefine data integration by delivering a no-code enterprise solution that unifies data movement, automation, and AI connectivity. “Our continued recognition reflects the trust of our customers and the innovation of our team,” said Don Murray, CEO and Co-Founder of Safe Software. “We’re proud to help organizations integrate data seamlessl
GENESIS Pharma announces a new partnership with Otsuka Pharmaceutical Europe Ltd. for the commercialization of donidalorsen for hereditary angioedema in Central and Eastern Europe15.12.2025 10:00:00 CET | Press Release
ANNOUNCEMENT FOR EUROPEAN MEDICAL & PHARMACEUTICAL TRADE MEDIA AND EUROPEAN FINANCIAL MEDIA ONLY GENESIS Pharma, a regional biopharma company focused on the commercialization of innovative medicines in Central and Eastern Europe, announces an exclusive agreementwithOtsuka Pharmaceutical Europe Ltd. (OPEL), the European operation of global healthcare company Otsuka Pharmaceutical Co., Ltd., for donidalorsen. Under the terms of the agreement, GENESIS Pharma will exclusively distribute and commercializedonidalorsen in fourteen markets: Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Greece, Hungary, Latvia, Lithuania, Malta, Poland, Romania, Slovakia and Slovenia. In November 2025, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for donidalorsen in the routine prevention of recurrent attacks of hereditary angioedema (HAE) in adults and adolescents aged 12 years and older. The CHMP opinion is c
BitGo yn Sicrhau Cymeradwyaeth OCC i Drosi i Fanc Ymddiriedolaeth Genedlaethol Siartredig Ffederal13.12.2025 02:13:00 CET | Pressmeddelande
Cyhoeddodd BitGo Holdings, Inc. (“BitGo”), y cwmni seilwaith asedau digidol, heddiw fod Swyddfa Rheolwr yr Arian Cyfred (“OCC”) wedi cymeradwyo ei gais i drosi BitGo Trust Company, Inc., cwmni ymddiriedolaeth siartredig De Dakota, i fanc cenedlaethol o'r enw BitGo Bank & Trust, National Association (N.A.). Gyda chymeradwyaeth OCC heddiw o'i drosi, mae is-gwmni Cwmni Ymddiriedolaeth BitGo bellach yn gweithredu fel BitGo Bank & Trust, National Association (N.A.). Bydd BitGo Bank & Trust, N.A. yn gweithredu o dan un gyfundrefn oruchwylio ffederal unffurf, gan ei alluogi i ddarparu'r eglurder, y llywodraethiant, a'r sicrwydd rheoleiddiol y mae sefydliadau'n eu disgwyl gan ymddiriedolwr a reoleiddir yn ffederal. Mae'r gymeradwyaeth hon yn atgyfnerthu safle BitGo fel sylfaen sefydliadol ar gyfer y system ariannol fodern, gan gyfuno goruchwyliaeth ar lefel banc â'r diogelwch, y cydymffurfiaeth, a'r graddadwyedd sy'n diffinio seilwaith BitGo. O dan siarter y banc cenedlaethol, ac yn amodol ar
FIA, Formula 1 Group and All 11 Race Teams Officially Sign the Ninth Concorde Agreement, Securing Strength and Stability for the Sport in Pivotal Five-Year Agreement12.12.2025 17:10:00 CET | Press Release
The Fédération Internationale de l'Automobile (FIA), the global governing body for motor sport and the federation for mobility organisations worldwide, and Formula 1 Group, the Commercial Rights Holder, have today announced the signing of the Concorde Governance Agreement, a crucial contract defining the regulatory framework and governance terms of the FIA Formula One World Championship until 2030. This follows the announcement in March that the 2026 Commercial Concorde Agreement had been signed by all the teams and Formula 1 Group. Together, these agreements constitute the ninth Concorde Agreement, representing a major step forward in the professionalisation and global development of the sport. First introduced in 1981, the Concorde Agreements are designed to promote sporting fairness, technological innovation and operational excellence, and align all key stakeholders around a shared vision for structured governance and continued growth of the sport. Each iteration of the Concorde Agr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom